Actio Biosciences
PrivateLast Round
Series B
Jun 18, 2025
Total Funding Raised
$137M
Momentum
Top 10%
of companies Caplight tracks
Company Overview
Actio Biosciences is a biotechnology company that develops precision medicines targeting the underlying genetic biology of rare diseases with potential applications for more prevalent indications.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine, Clinical Trials
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Actio Biosciences Comparables
Compare Actio Biosciences with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| GRIN Therapeutics, Inc. | 80% | |
| IAMA Therapeutics | 79% | |
| Praxis Precision Medicines, Inc. | 79% |
Actio Biosciences Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series B | Jun 18, 2025 | ||||
| Series A | Sep 12, 2023 | ||||
| Seed | May 1, 2022 | ||||
| Seed | Oct 1, 2021 |
Key People
Founding team and executive leadership
Actio Biosciences Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| EcoR1 Capital | Seed, Series A |
| Deerfield Management | Seed, Series A, Series B |
| Droia Ventures | Series A, Series B |
| Canaan Partners | Series B, Series A |
| Euclidean Capital | Series B, Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 28, 2026
Grew 23% QoQ, from 40 to 49 employees.
- Aug 22, 2026
Monthly visitors increased 33% MoM, reaching 4K.
Recent news
Latest coverage and updates
- is_developingAug 11, 2026
Actio Biosciences, Inc. is developing ABS-1230 on Aug 11th '26.
- receives_financingAug 10, 2026
Actio Biosciences, Inc. received financing of $1.3B on Aug 10th '26.
Actio Biosciences Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Actio Biosciences's valuation, stock price, and market status.
Is Actio Biosciences a public or private company?
Actio Biosciences is a private company.
What is the current stock price of Actio Biosciences?
Actio Biosciences is a private company with no public stock price. No recent secondary market data is available.
How much is Actio Biosciences worth (valuation)?
Valuation information for Actio Biosciences is not publicly available.
Can I buy Actio Biosciences stock?
Actio Biosciences shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Actio Biosciences's last funding round?
Actio Biosciences's most recent funding round was Series B on June 18, 2025.
Who are the main investors in Actio Biosciences?
Key investors in Actio Biosciences include Deerfield Management, Droia Ventures, Canaan Partners.
Will Actio Biosciences IPO soon?
No public IPO plans have been announced for Actio Biosciences.
How can I track Actio Biosciences secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Actio Biosciences's secondary market activity and sign up for updates.